Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G06Q-050/00
A61M-005/172
G06F-019/00
A61B-005/145
A61B-005/00
출원번호
US-0966101
(2013-08-13)
등록번호
US-9878096
(2018-01-30)
발명자
/ 주소
Roy, Anirban
Keenan, Desmond Barry
Mastrototaro, John J.
Grosman, Benyamin
Parikh, Neha J.
출원인 / 주소
MEDTRONIC MINIMED, INC.
대리인 / 주소
Lorenz & Kopf, LLC
인용정보
피인용 횟수 :
0인용 특허 :
200
초록▼
A controller for an insulin infusion device includes at least one processor device and at least one memory element that cooperate to provide a processor-implemented closed-loop start-up module. The start-up module is operated to initiate a closed-loop mode of the infusion device and to obtain a most
A controller for an insulin infusion device includes at least one processor device and at least one memory element that cooperate to provide a processor-implemented closed-loop start-up module. The start-up module is operated to initiate a closed-loop mode of the infusion device and to obtain a most recent sensor glucose value for the user. The start-up module also calculates a difference between the most recent sensor glucose value and a target glucose setpoint value. When the difference is less than or equal to a threshold value, the closed-loop insulin infusion rate is adjusted over time, based on a fixed final target glucose value that is derived from the target glucose setpoint value. When the difference is greater than the threshold, the infusion rate is adjusted over time, based on a dynamic final target glucose value that decreases over time toward the target glucose setpoint value.
대표청구항▼
1. An insulin infusion device comprising: an insulin reservoir for insulin to be delivered from the insulin infusion device to a body of a user;a processor architecture comprising at least one processor device; andat least one memory element associated with the processor architecture, the at least o
1. An insulin infusion device comprising: an insulin reservoir for insulin to be delivered from the insulin infusion device to a body of a user;a processor architecture comprising at least one processor device; andat least one memory element associated with the processor architecture, the at least one memory element storing processor-executable instructions that, when executed by the processor architecture, perform a method of controlling delivery of insulin from the insulin reservoir to the body of the user, the method comprising: initiating a closed-loop operating mode of the insulin infusion device, wherein during the closed-loop operating mode the insulin infusion device receives sensor glucose values from a continuous glucose sensor, and automatically controls delivery of insulin to the body of the user in response to at least the received sensor glucose values;in response to initiating the closed-loop operating mode, obtaining a most recent sensor glucose value for the user;calculating a difference between the most recent sensor glucose value and a target glucose setpoint value;when the calculated difference is less than or equal to a minimum threshold value, adjusting a closed-loop insulin infusion rate over time, based on a fixed final target glucose value that is derived from the target glucose setpoint value, and operating the insulin infusion device over time to deliver insulin from the insulin reservoir in accordance with the adjusted closed-loop insulin infusion rate; andwhen the calculated difference is greater than the minimum threshold value, adjusting the closed-loop insulin infusion rate over time by: calculating a dynamic glucose setpoint value for a current sampling point, wherein the dynamic glucose setpoint value is calculated in accordance with the expression DynSP(n)=cd1·DynSP(n−1)+cd2·DynSP(n−2)+cn0·DeltaGlu(n)+cn1·DeltaGlu(n−1), where cd1, cd2, cn0, and cn1 are coefficients of the discretized second order transfer function model, and for an initial calculation of the dynamic glucose setpoint value, DeltaGlu(n) is the difference, at the current sampling point, between the most recent sensor glucose value and the target glucose setpoint value;for the current sampling point, adding the calculated dynamic glucose setpoint value to the target glucose setpoint value to obtain a dynamic final target glucose value, wherein the dynamic final target glucose value is calculated in accordance with the expression FinalTarget(n)=Setpoint+DynSP(n), where n represents a current sampling point, FinalTarget(n) is the dynamic final target glucose value at the current sampling point, Setpoint is the target glucose setpoint value, and DynSP(n) is the dynamic glucose setpoint value at the current sampling point;for the current sampling point, adjusting the closed-loop insulin infusion rate in accordance with the obtained dynamic final target glucose value;for the current sampling point, operating the insulin infusion device to deliver insulin from the insulin reservoir in accordance with the adjusted closed-loop insulin infusion rate; andrepeating, for subsequent sampling points, the steps of calculating a dynamic glucose setpoint value, adding the calculated dynamic glucose setpoint value to the target glucose setpoint value, adjusting the closed-loop insulin infusion rate, and operating the insulin infusion device, wherein the method decreases the calculated dynamic glucose setpoint value over time such that the obtained dynamic final target glucose value approaches the target glucose setpoint value. 2. The insulin infusion device of claim 1, wherein the fixed final target glucose value is equal to the target glucose setpoint value. 3. The insulin infusion device of claim 1, wherein adjusting the closed-loop insulin infusion rate over time is performed in accordance with a proportional-integral-derivative insulin feedback (PID-IFB) control algorithm that calculates the closed-loop insulin infusion rate based on a proportional component, an integral component, and a derivative component, and further based on states of an insulin pharmacokinetic model corresponding to subcutaneous, plasma, and effective site compartments. 4. The insulin infusion device of claim 1, wherein each of cd1, cd2, and cn1 is based on two time constants of the discretized second order transfer function model. 5. The insulin infusion device of claim 1, wherein: DynSP(n−1) is equal to zero for an initial calculation of the dynamic glucose setpoint value;DynSP(n−2) is equal to zero for the initial calculation of the dynamic glucose setpoint value; andDeltaGlu(n−1) is equal to zero for the initial calculation of the dynamic glucose setpoint value. 6. A closed-loop insulin infusion system comprising: a continuous glucose sensor that generates sensor data indicative of sensor glucose values for a user; andan insulin infusion device coupled to receive the sensor data generated by the continuous glucose sensor, the insulin infusion device comprising an insulin reservoir for insulin to be delivered from the insulin infusion device to the user, a processor architecture comprising at least one processor device and further comprising at least one memory element associated with the processor architecture, the at least one memory element storing processor-executable instructions that, when executed by the processor architecture, cause the insulin infusion device to perform a method comprising: initiating a closed-loop operating mode of the insulin infusion device, wherein during the closed-loop operating mode the insulin infusion device receives sensor glucose values from the continuous glucose sensor, and automatically controls delivery of insulin to the body of the user in response to at least the received sensor glucose values;in response to initiating the closed-loop operating mode, obtaining a most recent sensor glucose value for the user;calculating a difference between the most recent sensor glucose value and a target glucose setpoint value;when the calculated difference is less than or equal to a minimum threshold value, adjusting a closed-loop insulin infusion rate over time, based on a fixed final target glucose value that is derived from the target glucose setpoint value, and operating the insulin infusion device over time to deliver insulin from the insulin reservoir in accordance with the adjusted closed-loop insulin infusion rate;when the calculated difference is greater than the minimum threshold value, adjusting the closed-loop insulin infusion rate over time by: calculating a dynamic glucose setpoint value for a current sampling point, wherein the dynamic glucose setpoint value is calculated in accordance with the expression DynSP(n)=cd1·DynSP(n−1)+cd2·DynSP(n−2)+cn0·DeltaGlu(n)+cn1·DeltaGlu(n−1), where cd1, cd2, cn0, and cn1 are coefficients of the discretized second order transfer function model, and for an initial calculation of the dynamic glucose setpoint value, DeltaGlu(n) is the difference, at the current sampling point, between the most recent sensor glucose value and the target glucose setpoint value;for the current sampling point, adding the calculated dynamic glucose setpoint value to the target glucose setpoint value to obtain a dynamic final target glucose value, wherein the dynamic final target glucose value is calculated in accordance with the expression FinalTarget(n)=Setpoint+DynSP(n), where n represents a current sampling point, FinalTarget(n) is the dynamic final target glucose value at the current sampling point, Setpoint is the target glucose setpoint value, and DynSP(n) is the dynamic glucose setpoint value at the current sampling point;for the current sampling point, adjusting the closed-loop insulin infusion rate in accordance with the obtained dynamic final target glucose value;for the current sampling point, operating the insulin infusion device to deliver insulin from the insulin reservoir in accordance with the adjusted closed-loop insulin infusion rate; andrepeating, for subsequent sampling points, the steps of calculating a dynamic glucose setpoint value, adding the calculated dynamic glucose setpoint value to the target glucose setpoint value, adjusting the closed-loop insulin infusion rate, and operating the insulin infusion device, wherein the method decreases the calculated dynamic glucose setpoint value over time such that the obtained dynamic final target glucose value approaches the target glucose setpoint value. 7. The closed-loop insulin infusion system of claim 6, wherein adjusting the closed-loop insulin infusion rate over time is performed in accordance with a proportional-integral-derivative insulin feedback (PID-IFB) control algorithm that calculates the closed-loop insulin infusion rate based on a proportional component, an integral component, and a derivative component, and further based on states of an insulin pharmacokinetic model corresponding to subcutaneous, plasma, and effective site compartments. 8. The closed-loop insulin infusion system of claim 6, wherein each of cd1, cd2, and cn1 is based on two time constants of the discretized second order transfer function model. 9. The closed-loop insulin infusion system of claim 6, wherein: DynSP(n−1) is equal to zero for an initial calculation of the dynamic glucose setpoint value;DynSP(n−2) is equal to zero for the initial calculation of the dynamic glucose setpoint value; andDeltaGlu(n−1) is equal to zero for the initial calculation of the dynamic glucose setpoint value. 10. The closed-loop insulin infusion system of claim 6, wherein the fixed final target glucose value is equal to the target glucose setpoint value.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (200)
Batina, William P.; White, Robert M., Acquisition circuit for cardiac pacer.
Schulman Joseph H. ; Lucisano Joseph Y. ; Shah Rajiv ; Byers Charles L. ; Pendo Shaun M., Alumina insulation for coating implantable components and other microminiature devices.
Tune Joel (Antioch IL) Anderson Robert L. (Boulder CO) Blankenship Larry (Boulder CO) Colesworthy ; III Daniel C. (Boulder CO) Heim Warren P. (Boulder CO) Miller ; III Scott A. (Boulder CO) Sherman B, Ambulatory infusion pump.
Coutr James E. (Concord MA) Griffin Wayne P. (Dracut MA) Crisler Charles M. (Windham NH), An infusion management and pumping system having an alarm handling system.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S. ; Friedman Keith A. ; Colman Fredric C., Analyte monitoring device and methods of use.
Steil, Garry M.; Rebrin, Kerstin; Goode, Jr., Paul V.; Mastrototaro, John J.; Purvis, Richard E.; Van Antwerp, William P.; Shin, John J.; Talbot, Cary D., Closed loop system for controlling insulin infusion.
Prestele Karl (Erlangen DEX) Franetzki Manfred (Uttenreuth DEX) Reif Erich (Erlangen DEX), Device for the infusion of fluids into the human or animal body.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Electrochemical analyte.
James Say ; Michael F. Tomasco ; Adam Heller ; Yoram Gal IL; Behrad Aria ; Ephraim Heller ; Phillip John Plante ; Mark S. Vreeke, Electrochemical analyte sensor.
Zhuang, Zhiming; Alberth, Jr., William P.; Foo, Ken K., Electronic device and method for determining a touch input applied to a capacitive touch panel system incorporated therein.
Gibson, Scott R.; Shah, Rajiv; Chernoff, Edward; Byers, Charles, Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat Zu Lubeck ; Klinik Fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat zu Lubeck ; Klinik fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Flex circuit connector.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville R. (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Bever, Glucose monitoring system.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville Rey (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Beve, Glucose sensor assembly.
McIvor, K. Collin; Cabernoch, James L.; Branch, Kevin D.; Van Antwerp, Nannette M.; Halili, Edgardo C.; Mastrototaro, John J., Glucose sensor package system.
Allen Douglas J. (Indianapolis IN) Johnson Kirk W. (Indianapolis IN) Nevin Robert S. (Indianapolis IN), Hydrophilic polyurethane membranes for electrochemical glucose sensors.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Wilson George S. (Lawrence KS) Bindra Dilbir S. (Lawrence KS) Hill Brian S. (Lawrence KS) Thevenot Daniel R. (Paris Cedex FRX) Sternberg Robert (Thiais FRX) Reach Gerard (Paris Cedex KS FRX) Zhang Ya, Implantable glucose sensor.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Gargano Diane A. ; Flachbart Eric J. ; Cowen Barry ; Duh Monica ; Rudser ; Jr. John L. ; Zhen Ken ; Noble Lynn ; Warhurst Julian ; Pedraza Luis, Infusion pump for at least one syringe.
Coutre James E. (114 Stone Root La. Concord MA 01742) Griffin Wayne P. (55 Surrey La. Dracut MA 01826) Crisler Charles M. (10 Sunridge Rd. Windham NH 03087), Infusion pump management system for suggesting an adapted course of therapy.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Say, James L.; Sakslund, Henning; Tomasco, Michael F.; Audett, Jay D.; Cho, Hyun; Yamasaki, Duane O.; Heller, Adam, Mass transport limited in vivo analyte sensor.
Castellano Thomas P. (Beverly Hills CA) Schumacher Robert (Beverly Hills CA), Medication delivery device with a microprocessor and characteristic monitor.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Peterson Bruce A. (Milwaukie OR) Hogard Michael E. (Oregon City OR) Johnson Harley D. (Portland OR) Kelly Thomas D. (Portland OR) Long Jean M. (Portland OR) Preston ; Jr. William G. (Portland OR), Method and apparatus for kidney dialysis.
Joseph H. Schulman ; Joseph Y. Lucisano ; Rajiv Shah ; Charles L. Byers ; Shaun M. Pendo, Method of applying insulation for coating implantable components and other microminiature devices.
Feldman, Benjamin J.; Heller, Adam; Heller, Ephraim; Mao, Fei; Vivolo, Joseph A.; Funderburk, Jeffery V.; Colman, Fredric C.; Krishnan, Rajesh, Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator.
Moberg, Sheldon B.; Causey, III, James D.; Bare, Rex O.; Scherer, Andrew J.; Sargent, Bradley J., Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Brown Stephen J. ; Jensen Erik K., On-line health education and feedback system using motivational driver profile coding and automated content fulfillment.
Roizen Michael (Chicago IL) Turcotte ; II William E. (Oak Park IL) Pfisterer Richard E. (Arlington Heights IL), Portable medical interactive test selector having plug-in replaceable memory.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Process for producing an electrochemical biosensor.
Livingston John H. (Los Angeles CA) Frye Ward K. (San Luis Obispo CA) Field Jeffrey F. (Northridge CA), Proctective case for a medication infusion pump.
Sancoff Gregory E. (Leucadia CA) McWilliams Mark (San Diego CA) Barr Howard S. (Escondido CA) Cordner ; Jr. Edward T. (Carlsbad CA) Barton Russell C. (Monrovia CA), Programmable infusion system.
Shin, John J.; Holtzclaw, Kris R.; Dangui, Nandita D.; Kanderian, Jr., Sami; Mastrototaro, John J.; Hong, Peter I., Real time self-adjusting calibration algorithm.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Epstein Paul (Brookline MA) Petschek Harry (Lexington MA) LaWhite Eric (South Royalton VT) Strohl Clair (Norfolk MA) Coyne Henry (Framington MA) Kaleskas Edward (Jefferson MA) Adaniya George (Swampsc, Remotely programmable infusion system.
Lundquist Ingemar H. (Pebble Beach CA) Tarczy-Hornoch Zoltan (Berkeley CA) Kardos Thomas J. (Laguna Beach CA), Retroperfusion and retroinfusion control apparatus, system and method.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Aoki Thomas T. (1021 El Sur Way Sacramento CA 95825), System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof.
Tacklind Christopher A. (Palo Alto CA) Sanders Matthew H. (Los Altos Hills CA) Walne Geoffrey B. (Atherton CA), System for monitoring and reporting medical measurements.
Blomquist Michael L. (Coon Rapids MN) Peterson Thomas L. (Shoreview MN), Systems and methods for operating ambulatory medical devices such as drug delivery devices.
Mann, Alfred E.; Purvis, Richard E.; Mastrototaro, John J.; Causey, James D.; Henke, James; Hong, Peter; Livingston, John H.; Hague, Clifford W.; Hite, Brad T., Telemetered characteristic monitor system and method of using the same.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Transcutaneous sensor insertion set.
Gerety, Eugene P.; Strempski, Richard A.; Sardi, Stephen G., Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same.
Carter,Scott J.; Flanders,Edward L.; Hannah,Stephen E., Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.